Related Experiment Video
Updated: Jun 6, 2026

04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Inhibition of JNK phosphorylation reverses memory deficit induced by β-amyloid (1-42) associated with decrease of
Mahmoudreza Ramin1, Pegah Azizi, Fereshteh Motamedi
1Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Behavioural Brain Research
|November 16, 2010
Summary
Inhibiting JNK (c-Jun N-terminal kinase) in rats with Alzheimer's disease models improved spatial memory. This suggests JNK inhibition may offer a new therapeutic strategy for Alzheimer's disease by reducing apoptosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by beta-amyloid (Aβ) plaques.
- Aβ plaque aggregation in the hippocampus is linked to memory impairment.
- Mitogen-activated protein kinase (MAPK) pathways, including JNK, are implicated in AD pathogenesis.
Purpose of the Study:
- To investigate the effect of a JNK inhibitor on spatial memory in a rat model of Aβ-induced Alzheimer's disease.
- To explore the potential neuroprotective mechanisms of JNK inhibition in the hippocampus.
Main Methods:
- Rats were injected with Aβ to induce Alzheimer's-like pathology.
- Spatial memory was assessed using the Morris water maze test.
- Apoptotic markers (caspase-3, TUNEL, Bcl-2/Bax ratio) and cyclooxygenase-2 were analyzed in hippocampal tissue.
Main Results:
- Administration of the JNK inhibitor SP600125 significantly improved spatial memory, reducing escape latency and increasing time in the target quadrant.
- SP600125 treatment decreased levels of caspase-3 and TUNEL-positive cells, indicating reduced apoptosis.
- The JNK inhibitor also reduced cyclooxygenase-2 and increased the Bcl-2/Bax ratio, suggesting anti-apoptotic effects.
Conclusions:
- JNK inhibition demonstrates neuroprotective effects against Aβ-induced memory deficits and apoptosis in rats.
- SP600125 may represent a promising therapeutic target for Alzheimer's disease treatment.

